RoboMed Selected for Health Incubator Helsinki Program

RoboMed, an innovative health startup, has been chosen to participate in the prestigious Health Incubator Helsinki program. This selection recognizes RoboMed’s groundbreaking robotic capsule for endoscopy, biopsy, and microbiota sampling of the small intestine. The technology promises to diagnose, predict, and prevent diseases through a minimally invasive method.

Overview of RoboMed’s Technology

RoboMed’s state-of-the-art robotic capsule streams live images and communicates via a smartphone app, making endoscopic procedures less invasive and more efficient. Equipped with biopsy needles, the capsule performs precise tissue sampling, aiding in early disease detection and prevention.

Benefits of Minimally Invasive Methods

Minimally invasive techniques, like RoboMed’s, reduce patient discomfort and recovery times while enhancing diagnostic accuracy. Real-time data transmission allows for immediate anomaly detection, improving patient outcomes.

Support from Health Incubator Helsinki

RoboMed will benefit from up to three years of customized mentoring, office space at Terkko Health Hub, and access to a vast network of investors and industry experts. The program’s support is crucial for refining RoboMed’s technology and expanding its market reach.

Future Prospects

With the incubator’s backing, RoboMed is poised for significant growth. The alignment with emerging trends in AI, telemedicine, and personalized medicine ensures that RoboMed’s technology remains at the forefront of healthcare innovation.


RoboMed’s participation in the Health Incubator Helsinki program marks a significant milestone. The support and resources provided will enable RoboMed to advance its robotic capsule technology, improving diagnostic procedures and patient care.